A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

Summary

A multicenter, open label, escalating dose study to assess the tolerability and the safety and to explore the efficacy and the pharmacokinetics of ND0801 in adult patients with attention deficit/hyperactivity disorder (ADHD).

Timeline

Start

2010-10

Primary completion

2017-06

Completion

2017-06

Drugs

Indications